SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.

McCormick & Co., Inc. - Ordinary Shares (Non Voting)

McCormick is trending as investors analyze the potential impact of its upcoming Q3 earnings report on trends in consumer demand and pricing strategies; the company is expected to release earnings soon. Options traders are showing significant activity, with call options outpacing puts. McCormick's defensive characteristics and recent breaking above resistance are also driving interest.

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Hologic, Inc.

$HOLX is trending following renewed takeover interest from Blackstone and TPG, with community members discussing potential acquisition prices. Bullish sentiment is also fueled by analysts raising price targets and reports of strong performance in key business segments, while others are eyeing potential technical breakouts.

Weyerhaeuser Co. engages in the manufacture, distribution, and sale of forest products. It operates through the following segments: Timberlands, Real Estate, Energy, and Natural Resources (Real Estate and ENR), and Wood Products. The Timberlands segment manages private commercial forestland worldwide and engages in growing and harvesting trees for lumber, building, pulp, paper, and other wood products. The Real Estate and ENR segment delivers premiums to timber value by identifying and monetizing higher and better use lands and capturing the full value of surface and subsurface assets. The Wood Products segment delivers lumber, structural panels, engineered wood products and complementary building products for residential, multi-family, industrial, and light commercial applications. The company was founded by Frederick T. Weyerhaeuser on January 18, 1900 and is headquartered in Seattle, WA.

Weyerhaeuser Co.

Weyerhaeuser ($WY) is trending as investors weigh the impact of potential lumber tariffs and interest rate cuts on the housing market. Community discussions revolve around dividend increases, buybacks, and the potential for a housing market rebound in 2026. Recent analyst ratings and price target adjustments from firms like DA Davidson and JP Morgan Chase are also contributing to the conversation.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate is trending due to optimism surrounding AI-driven demand for data storage, with analysts highlighting potential for revenue and margin expansion. Community members are actively discussing the company's prospects in the context of growing data needs and its position relative to competitors like Western Digital. Despite this, concerns about debt and valuation linger, creating a mixed sentiment around the stock's near-term potential.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

ISRG is trending as traders discuss the stock's potential upside, citing its leadership in surgical robotics and strong healthcare momentum. The community is actively evaluating entry points for call options, with some highlighting institutional participation and upcoming earnings as potential catalysts. However, some concerns remain around tariffs and margin pressure.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is trending due to a recent partnership with Volkswagen to enhance driver assistance systems, sparking optimism about the company's role in advancing autonomous driving technology. Community discussions revolve around the potential impact of this collaboration, with some anticipating a positive effect on Mobileye's stock performance. Despite some skepticism, the news has generated renewed interest in the autonomous driving sector.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors discuss its pipeline potential, particularly CAN-2409, with some highlighting upcoming data releases and potential catalysts in Q4. The community speculates on partnership opportunities and future catalysts, while also debating the company's valuation and management. Overall, community sentiment seems positive, but cautious, awaiting further developments.

Toilet Dust ($TOILET) is a meme coin created on the Sui blockchain, designed to add some humor and chaos to the crypto world while playing a key role in driving the growth and adoption of the Sui ecosystem. Unlike typical meme coins that focus solely on entertainment or speculation, $TOILET’s mission goes beyond just the jokes. It is committed to fostering a vibrant, active community that’s passionate about both crypto and fun, while encouraging new users to explore the Sui blockchain.  The project’s foundation is built on the idea that a thriving network benefits everyone—whether you're a crypto enthusiast, developer, or investor. By embracing the lighthearted and unpredictable nature of meme coins, $TOILET brings attention to the Sui ecosystem and attracts a diverse range of participants. As $TOILET grows, so does the network and its ecosystem, creating more opportunities for everyone involved.  In addition to just memes, $TOILET is actively working on expanding its presence across social media, building partnerships, and increasing its visibility in the crypto space. It’s about creating an inclusive environment where the community drives the project forward. So, whether you're in it for the laughs, the community, or the chance to be part of something new, Toilet Dust is here to make a splash—join the movement or get left behind!

Toilet Dust

Toilet Crypto ($TOILET) is trending amid community excitement surrounding its liquid NFTs and upcoming announcements, with many investors believing it will perform well on the SUI network. The team's engagement and upcoming PFP collection mint are also key discussion points. Some users are expressing concerns about the token's performance and potential for rug pulls, while others maintain a bullish outlook, anticipating significant gains.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI Corp. is trending as investors discuss its potential role in the expanding drone market, particularly concerning European and NATO border security. The community is focused on the company's AI capabilities and a recent board appointment, speculating about upcoming contracts and institutional interest. Bullish sentiment is fueled by the anticipation of significant gains, with some drawing parallels to Palantir's early growth.

Constellation Brands, Inc. engages in the production, marketing, and distribution of beer, wine, and spirits. It operates through the following segments: Beer, Wine and Spirits, Corporate Operations and Other, and Canopy. The Beer segment includes imported and craft beer brands. The Wine and Spirits segment sells wine brands across all categories-table wine, sparkling wine, and dessert wine-and across all price points. The Corporate Operations and Other segment refers to the costs of executive management, corporate development, corporate finance, human resources, internal audit, investor relations, legal, public relations, and information technology. The Canopy segment consists of canopy equity method Investments. The company was founded by Marvin Sands in 1945 and is headquartered in Rochester, NY.

Constellation Brands Inc - Ordinary Shares - Class A

Constellation Brands Inc

Constellation Brands ($STZ) is trending amid mixed sentiment ahead of earnings, with analysts debating its prospects. Some traders are eyeing potential upside based on options activity and oversold conditions, while others remain cautious due to concerns about consumer demand and tariffs. Discussions include the impact of potential trade deals and comparisons to other beverage companies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 737.7% in Aligos Therapeutics (ALGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia

SNY wins FDA approval for Wayrilz, the first BTK inhibitor for immune thrombocytopenia, with broader rare disease studies underway.

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study

Rocket Pharmaceuticals' shares soar as the FDA lifts its clinical hold on the pivotal Danon disease gene therapy study.

Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 983.2% in Aligos Therapeutics (ALGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus

ALLO posts a narrower second-quarter 2025 loss. The company advances multiple CAR T programs targeting cancer and autoimmune diseases.

Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates

Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of +34.89% and -3.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, Aligos ), a clinical stage biopharmaceutical company focused on developing novel...

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, Aligos ), a clinical stage biopharmaceutical company focused on developing novel...

Aligos Therapeutics initiates Phase 2a HERALD study of ALG-055009

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

Screening of subjects has begun at clinical study sitesThe Phase 2a study is being led by Principal Investigator, Dr. Stephen HarrisonAligos anticipates dosing the first subject in Q2 2024 with...

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.

Aligos Therapeutics Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

ALGS
Aligos Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ALGS News

ALGS Aligos Therapeutics Inc